PATENT CLAIM ANALYSIS

Application Number: 15942802
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-12
Patent Classification: ["514", "230500"]

Abstract:
The present invention is related to Selective Progesterone Receptor Modulators (SPRM) as described and defined herein, and covers the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of sexual hormone dependent diseases and gynaecological diseases in particular Endometriosis or Uterine Fibroids (UF), as a sole agent or in combination with other active ingredients wherein circulating endogenous estradiol concentration of treated women is maintained to a level in a range of 40 pg/mL to 85 pg/mL.

Claim (Index 2):
A Selective Progesterone Receptor Modulator (SPRM) namely (11\u03b2,17\u03b2)-17-Hydroxy-11-[4-(methylsulphonyl)phenyl]-17-(pentafluoroethyl)estra-4,9-dien-3-one (Compound 1) of formula (I) or a stereoisomer, a tautomer, a hydrate, a solvate, or a pharmaceutically acceptable salt thereof, or a mixture of same wherein Compound 1 is administered to women in need of treatment of a gynaecological disease, preferably, the disease is selected from Endometriosis, Uterine Fibroids (UF) and associated symptoms thereof in a daily dosage of 1 mg to 5 mg during a treatment period of four (4) weeks to one (1) year; wherein Compound 1 is administered for regulating the circulating endogenous estradiol concentrations in treated women to a level within the range of 40 pg/mL to 85 pg/mL during the treatment period and wherein the woman in need of treatment is defined as a female human that is suffering of Endometriosis, Uterine Fibroids (UF) and/or associated symptoms thereof and responding to Selective Progesterone Receptor Modulators (SPRM) treatment by a decrease of their circulating endogenous estradiol concentrations in blood plasma and/or presence of physiological changes as mentioned above wherein the Selective Progesterone Receptor Modulators (SPRM) thereof is never Compound 1.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 91.0
- Lexical Diversity: 1.33846
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13855559', '12990203', '14440023', '14251192', '12446567']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7942412771849668
- 35 USC 102 Novelty (BERT): 0.5287566672730157
- Combined Prediction Score: 0.7676928161937717
- Mean Citation Score: 317.07148400000005
- Max Citation Score: 345.38397000000015
- Similarity Product: 248.98619200615715

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test